Suppr超能文献

细胞周期调控和肿瘤抑制 RNA 的超编辑促进恶性祖细胞增殖。

Hyper-Editing of Cell-Cycle Regulatory and Tumor Suppressor RNA Promotes Malignant Progenitor Propagation.

机构信息

Division of Regenerative Medicine, Department of Medicine, Moores Cancer Center and Sanford Consortium for Regenerative Medicine, University of California, San Diego, La Jolla, CA, USA; Sanford Consortium for Regenerative Medicine, La Jolla, CA 92037, USA.

Division of Regenerative Medicine, Department of Medicine, Moores Cancer Center and Sanford Consortium for Regenerative Medicine, University of California, San Diego, La Jolla, CA, USA; Sanford Consortium for Regenerative Medicine, La Jolla, CA 92037, USA.

出版信息

Cancer Cell. 2019 Jan 14;35(1):81-94.e7. doi: 10.1016/j.ccell.2018.11.017. Epub 2019 Jan 3.

Abstract

Adenosine deaminase associated with RNA1 (ADAR1) deregulation contributes to therapeutic resistance in many malignancies. Here we show that ADAR1-induced hyper-editing in normal human hematopoietic progenitors impairs miR-26a maturation, which represses CDKN1A expression indirectly via EZH2, thereby accelerating cell-cycle transit. However, in blast crisis chronic myeloid leukemia progenitors, loss of EZH2 expression and increased CDKN1A oppose cell-cycle transit. Moreover, A-to-I editing of both the MDM2 regulatory microRNA and its binding site within the 3' UTR region stabilizes MDM2 transcripts, thereby enhancing blast crisis progenitor propagation. These data reveal a dual mechanism governing malignant transformation of progenitors that is predicated on hyper-editing of cell-cycle-regulatory miRNAs and the 3' UTR binding site of tumor suppressor miRNAs.

摘要

腺嘌呤脱氨酶与 RNA1(ADAR1)的失调与许多恶性肿瘤的治疗耐药性有关。在这里,我们表明 ADAR1 诱导的正常人类造血祖细胞中的高编辑会损害 miR-26a 的成熟,从而通过 EZH2 间接抑制 CDKN1A 的表达,从而加速细胞周期的过渡。然而,在急变期慢性髓性白血病祖细胞中,EZH2 表达的缺失和 CDKN1A 的增加会阻碍细胞周期的过渡。此外,MDM2 调节 microRNA 的 A 到 I 编辑及其在 3'UTR 区域内的结合位点稳定了 MDM2 转录本,从而增强了急变期祖细胞的增殖。这些数据揭示了一种双重机制,即通过细胞周期调节 microRNA 的高编辑和肿瘤抑制 microRNA 的 3'UTR 结合位点来控制祖细胞的恶性转化。

相似文献

2
ADAR1 promotes malignant progenitor reprogramming in chronic myeloid leukemia.ADAR1 促进慢性髓性白血病恶性祖细胞重编程。
Proc Natl Acad Sci U S A. 2013 Jan 15;110(3):1041-6. doi: 10.1073/pnas.1213021110. Epub 2012 Dec 28.

引用本文的文献

8
REMR: Identification of RNA Editing-mediated MiRNA Regulation in Cancers.REMR:癌症中RNA编辑介导的微小RNA调控的鉴定
Comput Struct Biotechnol J. 2024 Sep 18;23:3418-3429. doi: 10.1016/j.csbj.2024.09.011. eCollection 2024 Dec.

本文引用的文献

1
A-to-I RNA Editing Contributes to Proteomic Diversity in Cancer.A-to-I RNA 编辑促进癌症中的蛋白质组多样性。
Cancer Cell. 2018 May 14;33(5):817-828.e7. doi: 10.1016/j.ccell.2018.03.026. Epub 2018 Apr 26.
2
3
RNA editing with CRISPR-Cas13.使用CRISPR-Cas13进行RNA编辑。
Science. 2017 Nov 24;358(6366):1019-1027. doi: 10.1126/science.aaq0180. Epub 2017 Oct 25.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验